Related Experiment Video
Updated: Aug 6, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Radioreceptor assays of ipratropium bromide in plasma and urine
K Ensing1, M Pol, R A De Zeeuw
1State University, Department of Toxicology, A. Deusinglaan 2, 9713 AW Groningen, The Netherlands.
Abstract:
Ipratropium bromide (Ipbr) is a frequently used quaternary anticholinergic administered by inhalation in the treatment of chronic obstructive lung diseases. Hardly any pharmacokinetic data are available, which can be useful in the optimisation of anticholinergic therapies. Hence, a radioreceptor assay (RRA) for Ipbr has been developed. The RRA is based on the competition between (3)H-N-methylscopolamine chloride ((3)H-NMS) and Ipbr for binding to lyophilised muscarinic receptors from calf brains. The assay has been optimised in respect of incubation conditions and extraction by ion-pair formation with sodium picrate. Detection limits of the drug were 5 ng ml(-1) in urine and 500 pg ml(-1) in plasma, after extraction of 2-ml samples. The method is applicable to monitoring the drug in plasma and urine after therapeutic dosing.
Related Concept Videos
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Urine Studies I: Urinalysis

